E. Vischer
Impact in
- Pharmaceutical Science top 5%
- Chemical Reactions and Isotopes
- Microbiology top 10%
Papers in
-
- Steroid Chemistry and Biochemistry 15
- Phytochemical Studies and Bioactivities 2
-
- Microbial Natural Products and Biosynthesis 6
- Pharmacogenetics and Drug Metabolism 3
- Co-authors
- A. Wettstein (19 shared papers)H. Bickel (8 shared papers)Ch. Meystre (5 shared papers)V. Prelog (3 shared papers)W. Keller‐Schierlein (3 shared papers)Hans Zähner (4 shared papers)W. Voser (3 shared papers)Julius Schmidlin (2 shared papers)
- Journals
- Helvetica Chimica Acta (17 papers)Cellular and Molecular Life Sciences (5 papers)Advances in enzymology and related areas of molecular biology/Advances in enzymology and related subjects (1 paper)Angewandte Chemie (1 paper)
- Partner nations
- SwitzerlandGermany
In The Last Decade
E. Vischer
24 papers receiving 774 citations
Peers
Comparison fields: 5 of 95
- Pharmaceutical Science 87
- Microbiology 8
- Pharmacology 76
- Molecular Biology 557
- Pharmacology 121
Countries citing papers authored by E. Vischer
This map shows the geographic impact of E. Vischer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Vischer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Vischer more than expected).
Fields of papers citing papers by E. Vischer
This network shows the impact of papers produced by E. Vischer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Vischer. The network helps show where E. Vischer may publish in the future.
Co-authors
The 20 scholars most cited alongside E. Vischer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1960 | 130 | |
| 2 | 1960 | 124 | |
| 3 | 1960 | 108 | |
| 4 | 1953 | 84 | |
| 5 | 1968 | 83 | |
| 6 | 1958 | 47 | |
| 7 | 1956 | 43 | |
| 8 | 1960 | 41 | |
| 9 | 1955 | 41 | |
| 10 | 1955 | 37 | |
| 11 | 1955 | 37 | |
| 12 | 1954 | 33 | |
| 13 | 1960 | 31 | |
| 14 | 1952 | 27 | |
| 15 | 1962 | 25 | |
| 16 | 1963 | 25 | |
| 17 | 1954 | 24 | |
| 18 | 1963 | 23 | |
| 19 | 1960 | 16 | |
| 20 | 1961 | 12 |
About E. Vischer
E. Vischer is a scholar working on Molecular Biology, Pharmacology, Organic Chemistry, Pharmaceutical Science and Pharmacology, having authored 24 papers that have together received 1.0k indexed citations. Recurring topics across this work include Steroid Chemistry and Biochemistry (15 papers), Microbial Natural Products and Biosynthesis (6 papers), Chemical Reactions and Isotopes (4 papers), Pharmacogenetics and Drug Metabolism (3 papers), Synthetic Organic Chemistry Methods (3 papers), Estrogen and related hormone effects (2 papers), Phytochemical Studies and Bioactivities (2 papers) and Chromium effects and bioremediation (2 papers). The work is most often cited by research in Pharmaceutical Science (87 citations), Microbiology (8 citations), Pharmacology (76 citations), Molecular Biology (557 citations) and Pharmacology (121 citations). E. Vischer has collaborated with scholars based in Switzerland and Germany. Frequent co-authors include A. Wettstein, H. Bickel, Ch. Meystre, V. Prelog, W. Keller‐Schierlein, Hans Zähner, W. Voser, Julius Schmidlin, P Reusser and E. Gäumann. Their work appears in journals such as Helvetica Chimica Acta, Cellular and Molecular Life Sciences, Advances in enzymology and related areas of molecular biology/Advances in enzymology and related subjects and Angewandte Chemie.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.